SCHEMBL1734301

SCHEMBL1734301

COc1ccccc1-c1cc(C(N)=O)nc(N(C)C2CCCO2)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ADORA3 P0DMS8 4/20 0.39
OXTR P30559 2/20 0.39
AVPR1A P37288 2/20 0.39
POLB P06746 2/20 0.39
VCP P55072 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
IKBKB O14920 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ADORA1 P30542 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADORA2A P29274 1/20 0.37
CDK9 P50750 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1734650 0.82 ALDH1A1 (0.47) ALDH1A1HSD17B10MEN1KMT2AVCP
SCHEMBL1733692 0.80 ADORA3 (0.49) ALDH1A1HSD17B10ADORA3NPC1RAB9A
SCHEMBL1734302 0.77 MEN1 (0.51) ALDH1A1HSD17B10MEN1KMT2APOLB
SCHEMBL1734511 0.75 KDM4E (0.66) ALDH1A1HSD17B10ADORA3NPC1RAB9A
SCHEMBL1734495 0.73 KDM4E (0.51) ALDH1A1HSD17B10ADORA3NPC1RAB9A
SCHEMBL1734497 0.73 KDM4E (0.47) ADORA3VCPKDM4EADORA1ADORA2A
SCHEMBL2816888 0.72 HSP90AA1 (0.52) ALDH1A1ADORA3POLBIKBKBKDM4E
SCHEMBL1733468 0.71 KDM4E (0.57) ALDH1A1HSD17B10ADORA3NPC1RAB9A
SCHEMBL1734273 0.69 ALDH1A1 (0.65) ALDH1A1HSD17B10MEN1KMT2AADORA3
SCHEMBL1734398 0.69 CHRNA7 (0.49) ALDH1A1HSD17B10MEN1KMT2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891018-B1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2011-11-16 EP claimed
WO-2011131686-A1 A THERMALLY CONTROLLED ASSEMBLY NAPATECH A/S (DK) 2011-10-27 WO claimed
US-20070105833-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2007-05-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105833-A1 Modulators of ATP-binding cassette transporters ABCC4, CFTR, ABCC2 ALDH1A1 2670/4885HSD17B10 2845/4885MEN1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.